Home > Insider Trading > Filing (0001209191-11-002541)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1131324	Genomic Health Inc	GHDX	Services-Medical Laboratories (8071)	770552594

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1337798	Bradley G Cole	301 Penobscot Drive Redwood City CA 94063	Coo	No	Yes	No	No

Transaction Summary

Sold:	5,000 shares	Avg. Price: $22.13	Total Value: $110,652.00
Number of Shares After Transactions:	1,000 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-01-06	5,000	$1.33	6,000	No	4	M	Direct
Common Stock	Disposition	2011-01-06	5,000	$22.13	1,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2011-01-06	5,000	$0.00	5,000	$1.33

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
92,868		2014-07-06	No	4	M	Direct

Footnotes

The number of shares originally covered by the exercised option was 150,000 with an exercise price per share of $1.38. In connection with the issuer's initial public offering on October 4, 2005, a conditional dividend was issued which increased the number of shares covered by the option by 6,033 to 156,033, reducing the effective exercise price per share to $1.33.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 12, 2009.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $21.83 to $22.53.
The option becomes exercisable as to 25% of the shares on July 6, 2005, and becomes exercisable as to 1/48th of the shares each full month thereafter.